<div id="readability-page-1"><p>LVM Capital Management Ltd. MI lessened its position in shares of  Icon Plc (NASDAQ:ICLR - Free Report) by 18.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 32,989 shares of the medical research company's stock after selling 7,614 shares during the quarter. LVM Capital Management Ltd. MI's holdings in Icon were worth $5,773,000 at the end of the most recent reporting period.</p><ul><li>3 Healthcare Pathbreakers With Long-Term Tailwinds</li></ul><p>Several other hedge funds also recently added to or reduced their stakes in ICLR. SVB Wealth LLC acquired a new stake in  Icon during the first quarter worth $28,000.  Ameritas Advisory Services LLC purchased a new position in shares of  Icon during the 2nd quarter worth $48,000.  LRI Investments LLC purchased a new position in shares of  Icon during the 2nd quarter worth $49,000.  Blue Trust Inc. raised its holdings in  Icon by 44.0% in the 2nd quarter. Blue Trust Inc. now owns 393 shares of the medical research company's stock valued at $57,000 after buying an additional 120 shares during the period.  Finally, Caitong International Asset Management Co. Ltd raised its holdings in  Icon by 40,800.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 409 shares of the medical research company's stock valued at $59,000 after buying an additional 408 shares during the period. 95.61% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>Icon Trading Down 2.8%</h2><p>NASDAQ ICLR opened at $173.77 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market cap of $14.03 billion, a price-to-earnings ratio of 23.51, a PEG ratio of 3.31 and a beta of 1.25. The firm has a 50 day simple moving average of $175.78 and a 200-day simple moving average of $168.15. Icon Plc has a one year low of $125.10 and a one year high of $228.29. </p><h2>Wall Street Analysts Forecast Growth</h2><ul><li>Should You Bring The Luck Of The Irish To Your Investmets?</li></ul><p>Several research analysts have weighed in on the stock. Zacks Research raised shares of Icon from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, November 25th. Rothschild &amp; Co Redburn upgraded shares of Icon from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and upped their price objective for the stock from $184.00 to $236.00 in a report on Wednesday, September 3rd. Robert W. Baird  set a $220.00 price objective on shares of Icon in a research report on Friday, October 24th. TD Cowen dropped their target price on shares of Icon from $183.00 to $172.00 and set a &#34;hold&#34; rating for the company in a report on Friday, October 24th. Finally, Weiss Ratings  restated a &#34;hold (c)&#34; rating on shares of Icon in a research note on Monday. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and eleven have issued  a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $205.31.</p><p><b>Get Our Latest Research Report on ICLR</b></p><h2>About Icon</h2> (Free Report)<p>Icon plc <span>NASDAQ: ICLR<span></span></span> is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.  </p><p>Icon's service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Icon</li><li>What is Insider Trading? What You Can Learn from Insider Trading</li><li>Nike Beats on Earnings But Struggles in China and Faces Tariffs</li><li>What is the Hang Seng index?  </li><li>Is the AI Boom a Bubble? These 2 Dividend Stocks Say No</li><li>How to Use the MarketBeat Stock Screener </li><li>4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More</li></ul><p><strong>Want to see what other hedge funds are holding ICLR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Icon Right Now?</h2><p>Before you consider Icon, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Icon wasn't on the list.</p><p>While Icon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ICLR

<p>LVM Capital Management Ltd. MI reduced its stake in Icon Plc by 18.8% in the 3rd quarter, selling 7,614 shares. The firm's holdings are now valued at $5,773,000. Icon Plc, a global provider of drug development services, has a market cap of $14.03 billion. Analysts have mixed ratings on the stock, with a consensus target price of $205.31.</p>

Icon Plc $ICLR Shares Sold by LVM Capital Management Ltd. MI